Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels

References

• FRAILE, L. J., ARAMAYONA, J. J., BREGANTE, M. A., GARCIA, M. A. and ABADIA, A. R., 1996, Deacetylation of diltiazem by several rabbit tissues. Pharmaceutical Research, 13, 1875–1880.
   PubMedGoogle Scholar
• FRAILE, L. J., ARAMAYONA, J. J., BREGANTE, M. A., GARCIA, M. A. and SOLANS, C., 1997, Enhanced diltiazem deacetylase activity in pre-term and full-term rabbits compared with adult rabbits. Biology of the Neonate, 72, 51–61.
   PubMedGoogle Scholar
• HILDEBRANDT, R., WEITZEL, H., WARNKE, K. and GUNDERT-REMY, U., 1993, Pharmacokinetics of fenoterol in pregnant and nonpregnant women. European Journal of Clinical Pharmacology, 45, 275–277.
   Google Scholar
• HOLBROOK, R. H., GIBSON, R. N. and Voss, E. M., 1988, Tocolytic and cardiovascular effects of the calcium antagonist diltiazem in the near-term pregnant rabbit. American Journal of Obstetrics and Gynecology, 159, 591–595.
   PubMedGoogle Scholar
• HUSSAIN, M. D., TAM, Y. K., GRAY, M. R. and COUTTS, R. T., 1994, Mechanisms of time-dependent kinetics of diltiazem in the isolated perfused rat liver. Drug Metabolism and Disposition, 22, 36–42.
   PubMedGoogle Scholar
• JEFFRIES, W. S. and BOCHNER, F., 1988, The effect of pregnancy on drug pharmacokinetics. Medical Journal of Australia, 149, 675–677.
   PubMed Web of Science ®Google Scholar
• KNOTT, C., 1991, The treatment of hypertension in pregnancy: clinical pharmacokinetic considerations. Clinical Pharmacokinetics, 21, 233–241.
   PubMedGoogle Scholar
• LOEBSTEIN, R., LALKIN, A. and KOREN, G., 1997, Pharmacokinetics changes during pregnancy and their clinical relevance. Clinical Pharmacokinetics, 33, 328–343.
   PubMed Web of Science ®Google Scholar
• Los, L. E., WELSH, D. A., HEROLD, E. G., BAGDON, W. J. and ZACCHEI, A. G., 1996, Gender differences in toxicokinetics, liver metabolism, and plasma esterase activity: observations from a chronic (27-week) toxicity study of enalapril/diltiazem combinations in rats. Drug Metabolism and Disposition, 24, 28–33.
   PubMed Web of Science ®Google Scholar
• MITANI, G. M., STEINBERG, I., LIEN, E., HARRISON, C. and ELKAYAN, U., 1987, The pharmacokinetics of antiarrythmic agents in pregnancy and lactation. Clinical Pharmacokinetics, 12,253–291.
   PubMedGoogle Scholar
• NAKAMURA, S., SUZUKI, T., SUGAWARA, Y., USUKI, S., ITO, Y., KUME, T., YOSHIKAWA, M., ENDO, H., OHASHI, M. and HARIGAYA, S., 1987, Metabolic fate of diltiazem. Distribution, excretion and protein binding in rat and dog. Arzneim.-Forschl Drug Research, 37, 1244–1252.
   PubMedGoogle Scholar
• Nouws, J. F. M., 1992, Pharmacokinetics in immature animals: a review. Journal of Animal Science, 70, 3627–3634.
   PubMed Web of Science ®Google Scholar
• O'HARE, M. F., KINNEY, C. D., MURNAGHAN, G. A. and MCDEVITT, D. G., 1984, Pharmacokinetics of propranolol during pregnancy. European Journal of Clinical Pharmacology, 27, 583–587.
   Google Scholar
• RENTON, K. W., 1985, Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochemical Pharmacology, 34, 2549–2553.
   PubMedGoogle Scholar
• SUGAWARA, Y., NAKAMURA, S., USUKI, S., ITO, Y., SUZUKI, T., OSHASHI, M. and HARIGAYA, S., 1988, Metabolism of diltiazem. II. Metabolic profile in rat, dog, and man. Journal of Pharmaco-biodynamics, 11, 224–233.
   PubMedGoogle Scholar
• WEIR, M. R., 1995, Diltiazem: Ten years of clinical experience in the treatment of hypertension. Journal of Clinical Pharmacology, 35, 220–232.
   PubMed Web of Science ®Google Scholar
• WILSON, A. G. E., PICKETT, R. D., ELING, T. E. and ANDERSON, M. W., 1979, Studies on the persistence of basic amines in the rabbit lung. Drug Metabolism and Disposition, 76, 420–424.
   Google Scholar
• WITTER, F. R., 1993, Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy. Clinical Pharmacokinetics, 25, 444–449.
   PubMed Web of Science ®Google Scholar
• YABANA, H., NAGAO, T. and SATO, M., 1985, Cardiovascular effects of the metabolites of diltiazem in dogs. Journal of Cardiovascular Pharmacology, 7,152–157.
   PubMed Web of Science ®Google Scholar
• YAMAOKA, K., NAKAGAWA, T. and UNO, T., 1978, Application of the Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetics. Journal of Pharmacokinetics and Bio-pharmaceutics, 6, 165–175.
   PubMed Web of Science ®Google Scholar
• YEUNG, P. K. F., MONTAGUE, T. J., Tsui, B. and MCGREGOR, C., 1989, High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers. Journal of Pharmaceutical Sciences, 78, 592–597.
   Google Scholar
• YEUNG, P. K. F., MOSHER, S. J., QUILLIAM, M. A. and MONTAGUE, T. J., 1990, Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits and rats. Drug Metabolism and Disposition, 18, 1055–1059.
   Google Scholar
• YEUNG, P. K. F., MOSHER, S. J. and POLLAK, P. T., 1991, Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. European Journal of Drug Metabolism and Pharmacokinetics, 16, 69–74.
   Google Scholar
• YEUNG, P. K. F., PRESCOTT, C., HADDAD, C., MONTAGUE, T. J., MCGREGOR, C., QUILLIAM, M. A., XEI, M., FARMER, P., Li, R. and KLASSEN, G. A., 1993, Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose. European Journal of Drug Metabolism and Pharmacokinetics, 18, 199–206.
   Google Scholar